NuVinAir ReKlenz-X is safe for use in vehicles and can be used without damaging the interior. Photo courtesy of NuVinAir

With the onset of COVID-19, the public is more aware than ever of cross-contamination, which extends from your home to your business to your car, and beyond.

NuVinAir announced that its latest product, ReKlenz-X, has gotten approval from the Environmental Protection Agency (EPA) as an eco-friendly disinfectant. The company's Houston affiliate, Brian Ross, is selling the product.

ReKlenz-X kills 99.9 percent of germs, bacteria, and viruses in a vehicle's interior without compromising the integrity of the cabin. The product is on the EPA's "List N", which includes disinfectants for use to combat SARS-CoV-2, the virus that causes COVID-19."NuVinAir has proudly been at the forefront of helping ensure healthier commutes to drivers and passengers since launching in 2015. Adding this EPA-approved, oxygen-infused product that actually kills what's behind the coronavirus gives us an exciting extension to our 'Total Health' application," says Kyle Bailey, NuVinAir Global's CEO and founder.

"Our science-backed ReKlenz-X disinfectant cleans, protects, and disinfects safely and effectively — it's everything our automotive partners need in guaranteeing their customers' confidence in a safer, healthier vehicle," he continues.

To clean, the proprietary product uses an oxygen-enriched formula to quickly kills bacteria and viruses by destroying their cell walls through a process called oxidation. According to NuVinAir, ReKlenz-X contains no harsh chemicals, sticky residue, or dangerous volatile organic compounds. The result is a disinfected vehicle with no chemical smell.

ReKlenz-X is available in 32-ounce spray bottles through automotive dealerships, detail shops, rental-car companies, service centers, and vehicle fleets.

"Until now, any possible solution for killing the coronavirus was wrought with harmful chemicals, expensive equipment, and residue-leaving application devices that destroy the vehicle's interior," said Troy Blackwell, Chief Operating Officer for NuVinAir Global. "As a disinfectant and sanitizer, it can be applied to all interior vehicle surfaces using a microfiber towel. Paired with our premier detailing solution, ReNuSurface, as well as our patented Cyclone treatment, it takes deep cleaning to a whole new level for our automotive partners and their customers."

Dallas, Texas-based NuVinAir sells their products through a franchise system, similar to Line-X's business model.

------

This article originally ran on AutomotiveMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

German biotech co. to relocate to Houston thanks to $4.75M CPRIT grant

money moves

Armed with a $4.75 million grant from the Cancer Prevention and Research Institute of Texas, a German biotech company will relocate to Houston to work on developing a cancer medicine that fights solid tumors.

Eisbach Bio is conducting a clinical trial of its EIS-12656 therapy at Houston’s MD Anderson Cancer Center. In September, the company announced its first patient had undergone EIS-12656 treatment. EIS-12656 works by suppressing cancer-related genome reorganization generated by DNA.

The funding from the cancer institute will support the second phase of the EIS-12656 trial, focusing on homologous recombination deficiency (HRD) tumors.

“HRD occurs when a cell loses its ability to repair double-strand DNA breaks, leading to genomic alterations and instability that can contribute to cancerous tumor growth,” says the institute.

HRD is a biomarker found in most advanced stages of ovarian cancer, according to Medical News Today. DNA constantly undergoes damage and repairs. One of the repair routes is the

homologous recombination repair (HRR) system.

Genetic mutations, specifically those in the BCRA1 and BCRA1 genes, cause an estimated 10 percent of cases of ovarian cancer, says Medical News Today.

The Cancer Prevention and Research Institute of Texas (CPRIT) says the Eisbach Bio funding will bolster the company’s “transformative approach to HRD tumor therapy, positioning Texas as a hub for innovative cancer treatments while expanding clinical options for HRD patients.”

The cancer institute also handed out grants to recruit several researchers to Houston:

  • $2 million to recruit Norihiro Goto from the Massachusetts Institute of Technology to MD Anderson.
  • $2 million to recruit Xufeng Chen from New York University to MD Anderson.
  • $2 million to recruit Xiangdong Lv from MD Anderson to the University of Texas Health Science Center at Houston.

In addition, the institute awarded:

  • $9,513,569 to Houston-based Marker Therapeutics for a first-phase study to develop T cell-based immunotherapy for treatment of metastatic pancreatic cancer.
  • $2,499,990 to Lewis Foxhall of MD Anderson for a colorectal cancer screening program.
  • $1,499,997 to Abigail Zamorano of the University of Texas Health Science Center at Houston for a cervical cancer screening program.
  • $1,497,342 to Jennifer Minnix of MD Anderson for a lung cancer screening program in Northeast Texas.
  • $449,929 to Roger Zoorob of the Baylor College of Medicine for early prevention of lung cancer.

On November 20, the Cancer Prevention and Research Institute granted funding of $89 million to an array of people and organizations involved in cancer prevention and research.

West Coast innovation organization unveils new location in Houston suburb to boost Texas tech ecosystem

plugging in

Leading innovation platform Plug and Play announced the opening of its new flagship Houston-area location in Sugar Land, which is its fourth location in Texas.

Plug and Play has accelerated over 2,700 startups globally last year with corporate partners that include Dell Technologies, Daikin, Microsoft, LG Chem, Shell, and Mercedes. The company’s portfolio includes PayPal, Dropbox, LendingClub, and Course Hero, with 8 percent of the portfolio valued at over $100 million.

The deal, which facilitated by the Sugar Land Office of Economic Development and Tourism, will bring a new office for the organization to Sugar Land Town Square with leasing and hiring between December and January. The official launch is slated for the first quarter of 2025, and will feature 15 startups announced on Selection Day.

"By expanding to Sugar Land, we’re creating a space where startups can access resources, build partnerships, and scale rapidly,” VP Growth Strategy at Plug and Play Sherif Saadawi says in a news release. “This location will help fuel Texas' innovation ecosystem, providing entrepreneurs with the tools and networks they need to drive real-world impact and contribute to the state’s technological and economic growth."

Plug and Play plans to hire four full-time equivalent employees and accelerate two startup batches per year. The focus will be on “smart cities,” which include energy, health, transportation, and mobility sectors. One Sugar Land City representative will serve as a board member.

“We are excited to welcome Plug and Play to Sugar Land,” Mayor of Sugar Land Joe Zimmerma adds. “This investment will help us connect with corporate contacts and experts in startups and businesses that would take us many years to reach on our own. It allows us to create a presence, attract investments and jobs to the city, and hopefully become a base of operations for some of these high-growth companies.”

The organization originally entered the Houston market in 2019 and now has locations in Bryan/College Station, Frisco, and Cedar Park in Texas.